[Primary hyperimmunoglobulinemic purpura].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D001327:Autoimmune Diseases; D002701:Chloramphenicol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007136:Immunoglobulins / Q000032:analysis; D007592:Joint Diseases / Q000209:etiology; D007841:Latex Fixation Tests; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D011694:Purpura, Hyperglobulinemic / Q000150:complications / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D012737:Sex Factors; D012871:Skin Diseases / Q000150:complications; D012877:Skin Manifestations; D014666:Vasomotor System / Q000503:physiopathology
D000906:Antibodies; D007136:Immunoglobulins; D006886:Hydroxychloroquine; D002701:Chloramphenicol; D011241:Prednisone
Le purpura hyperimmunoglobulinémique primitif.